partnership

R&D

In a new white paper, Lucid Strategy Consulting suggests three key themes for pharma strategists seeking market leadership in the Alzheimer's space.

Market Access

Unlocking the potential of novel medicines for Europe’s patients demands innovation beyond invention.

R&D

January and February this year weren't a story of a few dominant megadeals, but rather a dense constellation of cross‑disciplinary alliances.

R&D

For a biopharmaceutical company, contracting a CDMO that considers itself accountable to the patients can deliver a tangibly different experience.

R&D

An emerging consensus across sponsors, investigators, and regulators is that agility must become a defining attribute of CRO performance.

Digital

At Veeva Commercial Summit in Madrid, we spoke with Alexander Ulrich, Global Head of System Integration & Data Ownership at Boehringer Ingelheim.